Reports
| Status | Drug name | NICE TAs | Comments |
|---|---|---|---|
 |
Levofloxacin (SDU) | ||
|
Levomepromazine injection | Consultant initiation only |
|
|
Levomepromazine tablets (Nozinan®) | Consultant initiation only, ESCA |
|
|
Lidocaine 5% patch | For patients who have been treated in line with NICE CG173 Neuropathic pain in adults: pharmacological management in non-specialist settings but are still experiencing neuropathic pain associated with previous herpes zoster infection (post-herpetic neuralgia) |
|
|
Lignocaine 5% medicated plasters (30 plasters) | RICaD |
|
|
Linaclotide | For moderate to severe IBS-Constipation. For patients who have not responded adequately to or cannot tolerate all other suitable treatment options BUT BEFORE other agents with higher costs. |
|
|
Liothyronine tablets | ESCA in development |
|
|
Lisdexamfetamine | ESCAs and additional advice in relation to age of patient and CCG |
|
|
Lithium carbonate M/R tablet (Priadel) | Specialist initation only, ESCA |
|
|
Lithium citrate liquid priadel | Specialist initiation only, ESCA |
Drug status key
Formulary drugs are allocated a traffic light status. This provides guidance on where clinical and prescribing responsibilities lie in regard to the initiation and maintenance of prescribing.
Grey
Positive NICE TA and/or awaiting local clarification on place in therapy. Please contact your medicines optimisation team for more information.
Red
Initiation and maintenance of prescribing by specialists only.
Amber
Initiation and maintenance of prescribing by specialists and transfer to primary care prescribing when appropriate, or in primary care following a specialists recommendation. Prior to initiation some medicines may require committee agreement or a framework to support safe transfer and maintenance.
Green
Initiation and maintenance of prescribing by specialists, GPs and other qualified clinicians.
Blue
Under review at University Hospitals Birmingham NHS Foundation Trust.
